Volume 2, Issue 4, October 2016

The application to MEDLINE from European Heart Journal-Cardiovascular Pharmacotherapy has been accepted!

• Extract
• View article

Cardiovascular pharmacotherapy—2015 was a good year

• Extract
• View article

Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER

• Abstract
• View article

Erratum

• Extract
• View article

Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients

• Abstract
• View article
• Supplementary data

P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries

• Abstract
• View article
• Supplementary data

Sodium–glucose cotransporter 2 inhibition: cardioprotection by treating diabetes—a translational viewpoint explaining its potential salutary effects

• Abstract
• View article

SGLT1 does compensate for SGLT2 inhibition

• Extract
• View article

A translational viewpoint explaining its potential salutary effects

• Extract
• View article

Melatonin has multiorgan effects

• Abstract
• View article

The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent

• Abstract
• View article